Danish Anapa Biotech has streamlinedits business to focus solely on a new molecular diagnostictechnology. "We expect to sign one or more agreements with large companies in the foreseeable future," says the CEO.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.